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Research
There has been considerable scientific research
to understand the potential link between resi-
dential and occupational exposures to power-
frequency electric and magnetic fields (ELF)
and the occurrence of cancer and other diseases.
The “limited” association between childhood
leukemia and ELF found in epidemiologic
studies (evidence from epidemiologic studies is
a major force in driving ELF risk assessments),
along with “inadequate” animal data, has led to
the classification of magnetic fields by the
International Agency for Research on Cancer
(IARC) as a “possible human carcinogen”
(IARC 2002). Because childhood leukemia is
the outcome for which the scientific evidence is
strongest, it can be regarded as the critical effect
in risk assessment and risk evaluation. 
The combination of the association of
childhood leukemia with low-level, chronic
exposures on the one hand and the widespread
exposures to ELF on the other have made it
both necessary and difficult to develop consis-
tent public health policies on ELF exposure.
The need for such policies results from the
undisputed value of safe, reliable, and eco-
nomic electricity to society to maintain all the
benefits that this provides. Creating effective
policy in light of these critical considerations
requires an estimate of the potential public
health impact and associated uncertainties.
The attributable fraction (AF) can be used
to inform policies on ELF exposure. The AF,
based on an established exposure–disease
relationship, is the proportion of the caseload
(of disease) that is attributable to the exposure,
assuming there is a causal relationship. Hence,
the AF can be used to estimate the degree of
incidence reduction that would be expected if
the observed association were real and if expo-
sure were reduced. In this article we begin with
a description of what is known about ELF
exposure distributions in various countries.
Then, we calculate country-specific and world-
wide estimates of AF and attributable cases
based on dose–response functions of ELF and
childhood leukemia from two major pooled
analyses. We conclude with a discussion of the
variability and uncertainty in these estimates.
Although the causal relationship between mag-
netic fields and childhood leukemia has not
been established (IARC 2002; Kheifets et al.
2005a, 2005b), we present estimates of the
possible pubic health impact to provide poten-
tially useful input into policy analysis.
Methods
Exposure distributions. When evaluating the
risks from exposure to any biologically active
agent—physical, biological, or chemical—it is
important to understand the distribution and
magnitude of the exposure in the general popu-
lation. To effectively quantify the risks of child-
hood leukemia, if any, from exposure to ELF,
we must first obtain some estimate of the
degree of exposure in children. These exposures
differ from country to country because of a
number of factors, most notably the frequency
and voltage used for power distribution, and
population density. In the absence of a known
or even plausible biophysical mechanism on
which to base an etiologically relevant exposure
measure, the exposure summary used in most
epidemiologic studies has been the time-
weighted average field. There are two types of
studies from which the exposure distribution is
extracted: a) exposure surveys to provide esti-
mates of the exposure prevalence in the popula-
tion (P0), and b) case series from case–control
studies to provide estimates of P0 (prevalence
in controls) and the exposure prevalence in
children with childhood leukemia (P1). Each 
of these sources provides some advantages.
Case–control studies provide most relevant
measurements of exposure and focus on a
24-hr or longer measurement in the child’s
bedroom. Estimates from case–control studies,
however, might be biased if, for example,
restrictions on the population (e.g., to live
within a certain distance of power lines) make
the case–exposure prevalence in the study
different from the population prevalence; this
bias renders unusable the case and control
prevalence estimates from studies with expo-
sure-related restrictions. Even if cases were rep-
resentative of the population, the controls
would not be representative if matching has
been done and the matching factors are associ-
ated with exposure; in that case the P0 estimate
from the study would be biased upward,
toward P1. Fortunately, the most common
matching factors were child’s age and sex,
which appear to be almost independent of
exposure in the studies (Greenland 2001a).
Exposure surveys, on the other hand, typically
include both children and adults, as well as per-
sonal measurements throughout the day, and
thus are only tangentially related to the expo-
sure in the child’s bedroom. At the very least
the use of both of these sources provides a
range of relevant exposures and subsequently a
range of impact measures for consideration.
Five extensive surveys have been conducted
to evaluate ELF exposures of the general popu-
lation [Brix et al. 2001; Decat et al. 2005;
Electric Power Research Institute (EPRI)
1993; EMF Rapid Program 1998; Yang et al.
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netic fields (ELF) and childhood leukemia has led to the classification of magnetic fields by the
International Agency for Research on Cancer as a “possible human carcinogen.” This association is
regarded as the critical effect in risk assessment. Creating effective policy in light of widespread
exposure and the undisputed value of safe, reliable, and economic electricity to society is difficult
and requires estimates of the potential public health impact and associated uncertainties. 
OBJECTIVES: Although a causal relationship between magnetic fields and childhood leukemia has
not been established, we present estimates of the possible pubic health impact using attributable
fractions to provide a potentially useful input into policy analysis under different scenarios. 
METHODS: Using ELF exposure distributions from various countries and dose–response functions
from two pooled analyses, we calculate country-specific and worldwide estimates of attributable
fractions (AFs) and attributable cases.
RESULTS: Even given a wide range of assumptions, we find that the AF remains < 10%, with point
estimates ranging from < 1% to about 4%. For small countries with low exposure, the number of
attributable cases is less than one extra case per year. Worldwide the range is from 100 to 2,400
cases possibly attributable to ELF exposure.
CONCLUSION: The fraction of childhood leukemia cases possibly attributable to ELF exposure
across the globe appears to be small. There remain, however, a number of uncertainties in these AF
estimates, particularly in the exposure distributions.
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2004]. These surveys generally estimate that
approximately 4–5% had mean exposures
> 0.3 µT with the exception of Korea where
7.8% had mean exposures > 0.3 µT. Only
1–2% has median exposures in excess of
0.4 µT. See Tables 1 and 2 for details of the
exposure distributions used.
Estimating exposures using the case expo-
sures from case–control studies allows us to look
at a broader spectrum of countries and results in
a range of 0.5–6.6% having mean exposures
> 0.3 µT and 0.5–3.3% having median expo-
sures > 0.4 µT. Two countries, the United
States and Germany, had both exposure surveys
and case–control studies. In the United States
the mean exposures were virtually equal from
the two methods, but the case–control median
estimates were less than the survey median esti-
mates. In Germany the case–control mean
exposure estimates were substantially smaller
than the survey estimates (median estimates
were not available for the case–control study),
which could be due to regional differences and
the inclusion of occupational exposures in the
survey estimates. In some studies the exposure
distribution for 0.2–0.3 and 0.3–0.4 µT had to
be estimated, as data were given only for the
0.2- to 0.4-µT intervals; the ratio from the U.S.
Rapid Survey (EMF Rapid Program 1998;
7.8% for 0.2–0.3 µT and 2.4% for 0.3–4 µT)
was used to calculate these estimates. 
In addition to assuming no significant dif-
ference in the exposure distributions based on
exposure surveys and case–control studies, we
have assumed that exposures obtained using
personal measures are equivalent to those from
household measurements, regardless of the
length of time of measurement and regardless
of whether they were for children or adults.
This last assumption was tested using average
and geometric mean household measurements
(bedroom and home) from the U.S. Rapid
Survey (EMF Rapid Program 1998), which
included a sample of both children and adults.
A two-sample t-test with equal variances com-
paring the distributions of the log of the aver-
age measurements of total home exposure
showed no significant difference between the
distributions for children (< 15 years) and
adults (≥ 15 years). Also, no significant differ-
ence was found between the adult and child
distributions of the log of the geometric mean
of total household exposure. The tests
described above assumed that the log of the
exposure is normally distributed, an assump-
tion that we tested and found to fit the data
well. Additional tests were conducted using
either the Pearson chi-square or Fisher’s exact
tests to compare the percent of people > 0.3 or
0.4 µT for children and adults; these tests
showed no significant difference in the percent
of children and adults above these exposure
levels for total household ELF exposure. 
Dose response. Dose–response functions
from two pooled analyses were used for esti-
mating the risk ratios (RRs). In one pooled
analysis based on nine well-conducted studies,
virtually no excess risk was noted for exposure
to ELF magnetic fields < 0.4 µT geometric
mean exposure and a 2-fold excess risk was
seen for exposure > 0.4 µT: The effect esti-
mates and associated 95% confidence intervals
(CIs) for all categories in relation to the low-
est exposure category of < 0.1 µT are as fol-
lows: 1.08 (0.89–1.31) for exposures 0.1 µT
to < 0.2 µT, 1.11 (0.84–1.47) for 0.2 µT to
< 0.4 µT, and 2.00 (1.27–3.13) for exposures
≥ 0.4 µT (Ahlbom et al. 2000).
The other pooled analysis included 15
studies based on less restrictive inclusion crite-
ria and used 0.3 µT arithmetic mean exposure
as the highest cutpoint (Greenland et al.
2000). The effect estimates and associated
95% CI for all categories in relation to the
lowest exposure category of ≤ 0.1 µT are as fol-
lows: 1.01 (0.84–1.21) for exposures > 0.1 µT
to ≤ 0.2 µT, 1.06 (0.78–1.44) for > 0.2 µT to
≤ 0.3 µT, and 1.68 (1.23–2.31) for exposures
> 0.3 µT (Greenland et al. 2000).
Overall, the two analyses are in close
agreement, but one of the differences between
the two pooled analyses is in the exposure
metric used: Ahlbom et al. (2000) examined
the association between the geometric mean
ELF level and childhood leukemia in 9 epi-
demiologic studies, whereas Greenland et al.
(2000) used the arithmetic mean to examine
this association in 12 studies. The other dif-
ference between the analyses of Ahlbom et al.
and Greenland et al. is the exposure catego-
rization: < 0.1 µT, 0.1 to < 0.2 µT, 0.2 to
< 0.4 µT, and ≥ 0.4 µT in Ahlbom et al.
(2000), and ≤ 0.1 µT, > 0.1 to ≤ 0.2 µT, > 0.2
to ≤ 0.3 µT, and > 0.3 µT in Greenland et al.
(2000). Greenland (2005) extended the
analysis to include 14 studies using a cut point
at 0.3 µT with similar results. Because most
ELF exposure data are skewed, the log-normal
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Table 1. Exposure distributions of arithmetic mean (µT) ELF measurements.a
Magnetic field category (µT)
Country Study Study type Measurement ≤ 0.1 (%) > 0.1 – ≤ 0.2 (%) > 0.2 – ≤ 0.3 (%) > 0.3 (%) n
Belgium Decat et al. 2005 Exposure survey 24-hr personal 81.9 11.5 1.6 5.1 251
Canada McBride et al. 1999b Case–control 48-hr personal 58.59 25.93 10.77 4.71 297
Germany Michaelis et al. 1998b Case–control 24-hr bedroom 85.23 9.66 1.70 3. 176
Brix et al. 2001 Exposure survey 24-hr personal 73.6 17.8 4.1 4. 1,952
Schuz et al. 2001c Case–control 24-hr bedroom 91.83 6.42 0.97 0.7 514
Japan Kabuto et al. 2006c Case–control 7-day home 88.46 5.77 3.85 1.92 312
Korea Yang et al. 2004 Exposure survey 24-hr personal 64.0 24.2 4.0 7.8 409
United Kingdom UKCCS 1999c Case–control 48-hr home 92.73 5.31 1.49 0.47 1,073
United States London et al. 1991b Case–control 24-hr bedroom 67.90 18.52 3.09 10.49 162
Linet et al. 1997b Case–control 24-hr bedroom 63.17 23.82 6.43 6.58 638
EMF Rapid Program 1998 Exposure survey 24-hr personal 64.2 21.1 7.8 6.6 995
EPRI 1993 Exposure survey 24-hr home 72.3 17.5 5.6 4.6 987
UKCCS, UK Childhood Cancer Study. 
aBased on exposure of cases in case–control studies and all respondents in exposure surveys. bBased on Greenland et al. (2000) reported distribution for pooled analysis. cExposure
categories: < 0.1, 0.1 to < 0.2, 0.2 to < 0.4, ≥ 0.4.
Table 2. Exposure distributions of geometric mean (µT) ELF measurements.a
Magnetic field category (µT)
Country Study Study type Measurement < 0.1 (%) 0.1 – < 0.2 (%) 0.2 – < 0.4 (%) ≥ 0.4 (%) n
Belgium Decat 2005 Exposure survey 24-hr personal 91.9 4.1 2.8 1.2 251
Canada McBride et al. 1999b Case-control 48-hr personal 63.97 20.59 10.66 4.78 272
Germany Michaelis et al. 1998b Case-control 24-hr bedroom 89.14 6.86 2.86 1.14 175
United Kingdom UKCSS 1999b Case-control 48-hr home 94.87 3.54 1.21 0.37 1,073
United States EMF Rapid Program 1998b Exposure survey 24-hr personal 72.6 17.6 7.5 2.3 995
Linet et al. 1997b Case-control 24-hr bedroom 70.25 18.66 8.24 2.86 595
aBased on exposure of cases in case–control studies and all respondents in exposure surveys. bBased on Ahlbom et al. (2000) reported distribution for pooled analysis.
distribution is often assumed as an approxima-
tion. In statistical analyses of such data, we
usually take the log in order to equalize the
variance among groups and to produce approx-
imate normality, thereby conforming to the
usual assumptions. Mathematically, the mean
of the logged values is the log of the geometric
mean. For this reason, a number of researchers
use the geometric mean to summarize ELF
exposure data. Alternatively, some authors
argue that in a standard setting we need the
risk at average exposure for a group to be equal
to the average risk to that group (Crump
1998). This logic then leads to using the arith-
metic mean to summarize the data. Because
there are arguments for using both geometric
and arithmetic means, we present two sets of
AF estimates, one based on each type of mean.
Attributable fraction. The AF is based on
the counterfactual contrast between the num-
ber of cases in a population that occur when the
population is subject to a given exposure distri-
bution and the number that would occur in the
same population if that distribution were
changed (e.g., if exposure were reduced or elim-
inated by an intervention), assuming all other
population characteristics remain the same.
There are two basic pieces of information
needed to make a crude estimate of the AF: an
estimate of the exposure effect on the disease
and the prevalence of exposure in the popula-
tion. If no adjustment for covariates is needed,
these values are simply substituted into the
unadjusted (crude) AF formula (Levin 1953): 
AFp = P0(RR – 1)/[P0(RR – 1) + 1], [1]
where AFp is the estimated AF, RR is the risk
ratio estimate, and P0 is the estimated expo-
sure prevalence in the target population. In this
article we use this formula to compute the AF
for exposure survey studies.
For case–control studies with adjusted
odds ratios (ORs), Levin (1953) gives another
formula:
AFp = P1(RRa – 1)/RRa, [2]
where RRa is the adjusted rate ratio estimate
(study OR) and P1 is the exposure prevalence
among the cases in the target population
(Rothman and Greenland 1998). 
This formula has the advantages of requir-
ing no adjustment of P1 to be valid and is unaf-
fected by matching controls to cases. We used
both formulas, with minor differences in AF
and report only the results based on the
case–series exposure distribution (P1) here. To
make these calculations for the ELF–childhood
leukemia relation, as leukemia is a rare disease,
we can assume that the OR estimates the RR.
We must also assume that the risk ratio 
estimates the effect in the target population,
that there is no bias, and that there is no change
in the effect estimate moving from the study to
the target population (Greenland 2004). 
We also calculate the excess number of
cases attributable to exposure, which was
obtained by multiplying the AF by the total
number of cases. We used the reported upper
and lower confidence limits of the RR to com-
pute upper and lower bounds of the estimated
AF. It should be noted that the computed
upper and lower bounds for the estimated AF
holds only under the additional assumption
that the exposure distribution in the popula-
tion is known (or can be estimated). 
Attributable numbers. Leukemia is the
most common childhood malignancy, consti-
tuting more than one-third of all childhood
cancers. For children < 15 years of age, the
estimated number of new leukemia cases in
2000 was approximately 49,000 globally,
translating into an incidence rate of about
3 cases per 100,000 [International Association
of Cancer Registries (IACR) 2000]. See
Table 3 for the global distribution of child-
hood leukemia incidence rates. 
The number of cases attributable to EMF
can be estimated by multiplying the AF by the
total number of cases. The exposure distribu-
tions used to come up with country-specific
AFs represent only a handful of countries
across the world. We had exposure distribu-
tions, and hence AF estimates, for countries in
North America, Europe, and Asia. To calculate
a range of estimates for the attributable num-
ber (AN) for each continent, we used the low-
est and highest estimates of AFs in each
continent and multiplied each by the total
number of leukemia cases in the continent to
come up with a range of ANs. We used the
corresponding CIs of the AFs to compute a
derived 95% CI for the estimated number of
cases. Where there were no studies from any
representative country in the continent, such as
Africa, Latin America, and Oceania, the overall
lowest AF and highest AF estimates were used.
Note that the Yang et al. (2004) study, which
is based on a larger sample and considered
more representative for non-Western regions,
was used to calculate an upper range for
regions with unknown levels (Latin America,
Africa, Oceania). 
Exposure reduction scenario. The AN
numbers for high exposures are the numbers of
cases that would be averted if we were to elimi-
nate exposures > 0.3 µT or 0.4 µT. However,
realistically, it is difficult or impossible to deter-
mine locations in which such exposures exist
and to eliminate them. An alternative approach
Kheifets et al.
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Table 3. Global incidence of childhood leukemia for children < 14 years of age in 2000.
Childhood leukemia
Region Population of 0- to 14 year oldsa New casesb Incidence rate (per 100,000)
Africa 339,631,000 3,848 1.13
Asia 1,119,233,000 31,062 2.78
Europe 127,382,000 4,878 3.83
Latin America 165,828,000 6,367 3.84
North America 68,083,000 2,841 4.17
Oceania 8,018,000 283 3.53
World 1,828,175,000 49,000 2.68
aData from IACR (2000). bData from United Nations (2002).
Figure 1. Upper, lower, and point estimates of AF,
based on arithmetic mean exposure of ELF. Numbers
in parentheses indicate multiple studies for one
country. Figure is based on exposure distributions for
specific countries and estimate of effect from pooled
analysis by Greenland et al. (2000); Japan: Kabuto
et al. (2006); Korea: Yang et al. (2004)); Belgium: Decat
et al. (2005); Germany (1): Brix et al. (2001); Germany
(2): Schuz et al. (2001); United Kingdom: UKCCS
(1999); Canada: McBride et al. (1999); United States
(1): EMF Rapid Program (1998); United States (2):
Linet et al. (1997). Vertical bars indicate upper and
lower AF estimates.
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Figure 2. Upper, lower, and point estimates of AF,
based on geometric mean exposure of ELF. Numbers
in parentheses indicate multiple studies for one
country. Figure is based on exposure distributions for
specific countries and estimate of effect from pooled
analysis by Ahlbom et al. (2000): Belgium: Decat et al.
(2005); Germany: Michaelis et al. (1998); United
Kingdom: UKCSS (1999); Canada: McBride et al.
(1999); United States (1): EMF Rapid Program (1998);
United States (2): Linet et al. (1997). Vertical bars indi-
cate upper and lower AF estimates.
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might be an attempt to reduce exposures where
possible to do so at no or low cost (Kheifets
et al. 2005a).
To evaluate this approach, we estimated
the impact of a hypothetical scenario where
the population’s exposure distribution is
reduced by 50%; in other words, each child
receives half the exposure he or she was previ-
ously getting. A new exposure distribution
was calculated to reflect this change. Because
the empirical distribution of exposure meas-
urements does not offer enough information
to estimate a distribution shift, we created a
calculated log-normal distribution based on
the mean, standard deviation, and lowest
observed value (0.01 µT). This type of detail
was available for only one of the distributions
(EMF Rapid Program 1998). Hence, our cal-
culated distribution and estimates of exposure
reduction are made only for the United
States. To make the current and 50% reduc-
tion scenarios more comparable, we based
both computations on the calculated, rather
than the actual, log-normal distribution. 
Results
Country-specific estimates. We computed
point estimates, as well as upper and lower
estimates of AFs for countries for which we
have access to an exposure distribution
(Figures 1, 2). For the United States and
Germany, where there were multiple distribu-
tions, the largest of the case–control studies
and the largest of the exposure surveys were
used. Despite large differences in the informa-
tion and assumptions from different studies
and countries, the estimate of AFs remains
low at around 3–4% and well below 1% for
some countries.
Potentially averted cases. AF and AN esti-
mates for exposures > 0.1, 0.2, 0.3 or 0.4 µT
were calculated for the arithmetic mean and
geometric mean exposure distributions, before
and after making the 50% exposure reduction
in the United States (Table 4). The differences
in the ANs reflect the numbers of cases that
would be potentially averted in the United
States because of the 50% exposure reduction.
Interestingly, 50% reduction in the lower
exposure categories (which is likely to be tech-
nically impossible and/or prohibitively expen-
sive) results in the number of cases similar in
magnitude to that which would be due to
high exposure only.
Worldwide estimates. The ANs of leu-
kemia cases were calculated for the scenarios of
eliminating arithmetic mean exposure
> 0.3 µT and of eliminating geometric mean
exposure ≥ 0.4 µT. This computation was
made for regions around the world, then added
to obtain a global estimate (Figures 3, 4). To
compute these regional estimates, we used the
lowest level and highest exposure levels esti-
mated in Tables 1 and 2 from the countries in
that region to obtain a regional range. Where
no information was available from any coun-
tries in the region, we used the lowest and
highest exposure levels overall. Making certain
assumptions about possible exposure reduction
scenarios, we provide a range of ANs thought
to be most useful for policymaking. Reducing
exposures to < 0.3 µT (arithmetic mean) or
0.4 µT (geometric mean) results in a number
Public health impact ELF
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Table 4. Point and low and high estimates (in parentheses) of the proportion (AF) and number (AN) of cases in the United States for the hypothetical scenario of
50% reduction in exposure of ELF.
Exposures above:
Arithmetic mean 0.1 µT 0.2 µT 0.3 µT
Proportion of all cases attributable to exposure (AF): current exposure distributiona 5.41% (–3.78%, 16.48%) 5.18% (–0.05%, 11.96%) 4.73% (1.65%, 8.73%)
Hypothetical distribution:b all exposures decreased by 50% 1.27% (–2.02%, 5.29%) 1.16% (–0.21%, 3.02%) 1.01% (0.34%, 1.93%)
Number of cases attributable to exposure (AN): current exposure distribution 138 (–97, 421) 133 (–1, 306) 121 (42, 223)
Hypothetical distribution: all exposures reduced by 50% 32 (–52, 135) 30 (–5, 77) 26 (9, 49)
Number of cases averted due to exposure reduction 105 (–45, 286) 103 (4, 228) 95 (33, 174)
Exposures above:
Geometric mean 0.1 µT 0.2 µT 0.4 µT
Proportion of all cases attributable to exposure (AF): current exposure distributiona 3.95% (–2.83%, 12.30%) 2.46% (–0.71%, 6.77%) 1.67% (0.46%, 3.49%)
Hypothetical distribution:b all exposures decreased by 50% 0.94% (–0.99%, 3.32%) 0.37% (–0.20%, 1.17%) 0.20% (0.05%, 0.42%)
Number of cases attributable to exposure (AN): current exposure distribution 101 (–72, 315) 63 (–18, 173) 43 (12, 89)
Hypothetical distribution: all exposures decreased by 50% 24 (–25, 85) 10 (–5, 30) 5 (1, 6)
Number of cases averted due to exposure reduction 77 (–47, 230) 53 (–13, 143) 38 (10, 83)
aCalculated log-normal distribution based on the EMF Rapid Program (1998). bCalculated log-normal distribution based on the EMF Rapid Program (1998), with all exposures reduced by 50%.
Figure 3. Estimated number and range of worldwide and regional cases of child-
hood leukemia among children < 14 years of age that are possibly attributable to
EMF arithmetic mean exposure > 0.3 µT (and the corresponding derived 95% CI).
Regional range is based on the lowest level and highest exposure levels from the
countries in a given region. Where there was no information from any countries
in the region, the overall lowest and highest exposure levels were used.
Figure 4. Estimated number and range of worldwide and regional cases of child-
hood leukemia among children < 14 years of age that are possibly attributable to
EMF geometric mean exposure ≥ 0.4 µT (and the corresponding derived 95% CI).
Regional range is based on the lowest level and highest exposure levels from the
countries in a given region. Where there was no information from any countries
in the region, the overall lowest and highest exposure levels were used.
of averted cases (assuming causality) ranging
from 100 to 2,400 cases annually worldwide. 
Discussion 
Since the first report suggesting an association
between residential ELF electric and magnetic
fields and childhood leukemia was published
in 1979 (Wertheimer and Leeper 1979),
dozens of increasingly sophisticated epidemio-
logic studies have examined this association.
In addition numerous comprehensive reviews,
meta-analyses, and two pooled analyses have
been published (e.g., Ahlbom et al. 2000;
Greenland et al. 2000; IARC 2002; National
Institute of Environmental Health Sciences
1999; National Research Council 1997).
Making certain assumptions about possible
exposure reduction scenarios, we provide a
range of ANs thought to be most useful for
policymaking. Globally, there is dispropor-
tionately more information on exposure from
industrialized countries; there are a number of
regions of the world, such as Africa and Latin
America, where no representative information
on exposure is available. Although the ORs
from different study regions (when available)
are similar, there are substantial differences in
the exposure distributions even within coun-
tries. Comparable or larger differences are
expected to exist elsewhere (e.g., exposures in
China and India are probably very different
from those in Korea). Therefore, the AF esti-
mates cannot be confidently generalized to
developing countries. Moreover, because
these calculations are highly dependent on the
exposure distribution and other assumptions,
they are very imprecise. For small countries
with low exposure, the number of attributable
cases is less than one extra case per year.
Worldwide the range is from 100 to 2,400
cases per year, possibly attributable to ELF
exposure, representing a small proportion of
total leukemia cases.
Uncertainty. Random error has many
components, including temporal and geo-
graphic variation, inter- and intraperson varari-
ability, as well as errors in measurement.
Intraperson, temporal, and geographic variabil-
ity are usually accounted for by averaging meas-
urements made via personal monitors and/or
measurements made in several locations over a
specified period of time; this is essential and
many ELF studies include extensive measure-
ments, often with frequent sampling during
measurement periods. Methods are available to
account for errors in measurement (Carrol
et al. 1995), but all studies on ELF effects
ignore this aspect. Consequently, these studies
most likely underestimate the true degree of
uncertainty of their conclusions (Greenland
2001b, 2003, 2005; Phillips 2003). 
In childhood leukemia, both pooled analy-
ses performed in 2000 were based on large
numbers and hence resulted in RR estimates
with tight confidence intervals. When analyses
are compared, they demonstrate consistency in
the size of their effect estimates and range of
confidence intervals. It appears unlikely that
random variability (or chance) played a signifi-
cant role in the observed effect estimates of
both pooled analyses. However, this does not
exclude the possibility that exposure was
assessed with a large degree of random error,
which could bias the observed RR toward the
null and introduce a lot of uncertainty into the
potential dose response. All attempts to exam-
ine potential confounding have not changed
the risk estimates and substantial confounding
from factors that do not represent an aspect of
the electric or magnetic fields is unlikely.
Selection bias may be partially responsible for
the consistently described epidemiologic associ-
ation between ELF and childhood leukemia
(Mezei and Kheifets 2005). A large study by
Linet et al. (1997) drives the overall risk esti-
mate in both pooled analyses and may have had
the greatest potential for selection bias, thereby
potentially inflating the risk estimate associated
with EMF exposure. Therefore, our estimates
of both AFs and ANs, which are based on the
pooled analyses, may similarly be overestimated
Conventional vs. Bayesian analysis. We
present calculations of AFs that do not reflect
any source of uncertainty other than random
error and offer some informal judgments
regarding the effect of possible biases. To pro-
vide additional input to policy analysis,
Greenland and Kheifets (2006) employed for-
mal Bayesian analyses to account for uncer-
tainties about study biases as well as
uncertainties about exposure distributions.
They developed a model to account for the
fraction attributable to exposure exceeding
0.3 µT and model the log of the counts of
cases as a linear function of whether the meas-
ured ELF exposure and the unmeasured
(unknown) true exposure is > 0.3 µT. Using
data from the published literature, they for-
mulated plausible prior distributions for
exposure parameters, rate ratios, uncontrolled
confounders, and for the degree of misclassifi-
cation. They then combined this information
to compute the posterior distribution of the
fraction attributable to the true exposure.
Their analyses support the idea that the pub-
lic health impact of residential fields is likely
to be limited, but the possibilities of both no
impact and a large impact remain in light of
the available data. The differences between
their analyses and ours vary in both direc-
tions, but generally the Bayesian results pro-
duce much wider bounds than ours.
Greenland and Kheifets (2006) argue that
conventional analyses such as the ones pre-
sented here may be overoptimistic and over-
confident. Nonetheless, we believe that both
the conventional and Bayesian approaches
offer policy analysts additional insights that
should be helpful in disentangling the uncer-
tainties inherent in this field. Using the sim-
pler conventional methods in this article, we
explore a variety of cut points, evaluate expo-
sure reduction scenarios, and calculate world-
wide estimates. 
Conclusion
At present it is not possible to decide whether
ELF exposure increases the risk of childhood
leukemia, which is reflected in the IARC classi-
fication of magnetic fields as a “possible” car-
cinogen. To estimate the potential public
health impact, we have calculated a range of
AFs under different scenarios. Even given a
wide range of assumptions, the AF remains
low, with point estimates ranging from < 1%
to about 4%. As the AF is highly dependent on
the exposure distribution, more data are
needed on exposure levels worldwide, which
should be collected in a large systematic survey
of an appropriately selected sample.
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